We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Clinigen Group Plc | LSE:CLIN | London | Ordinary Share | GB00B89J2419 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 925.00 | 924.50 | 925.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
TIDMBARC TIDMCLIN
RNS Number : 9617G
Barclays PLC
01 April 2022
Hot Features
Premium
FORM 8.5 (EPT/NON-RI)
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN
EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS
(OR WHERE RI STATUS IS NOT APPLICABLE)
Rule 8.5 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Name of exempt principal trader: BARCLAYS CAPITAL SECURITIES LTD
---------------------------------------------------
(b) Name of offeror/offeree in relation to whose CLINIGEN GROUP PLC
------------------------------------------------------
relevant securities this form relates:
------- --------------------------------------------------- --------------------------------------------------
(c) Name of the party to the offer with which exempt Triley Bidco Limited (a newly-formed company
indirectly owned by Triton Funds)
------------------------------------------------------
principal trader is connected
------- --------------------------------------------------- --------------------------------------------------
(d) Date position held/dealing undertaken: 31 March 2022
------- --------------------------------------------------- ------------------------------------------------------
(e) In addition to the company in 1(b) above, is the NO
exempt principal
trader making disclosures in respect of any other
party to the offer?
------- ----------------------------------------------------- --------------------------------------------------
2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER
(a) Interests and short positions in the relevant securities of the offeror or offeree
to which the disclosure relates following the dealing (if any)
Class of relevant security: 0.1p ordinary
-------------------------- ------------------------------
Interests Short Positions
-------------------------- ------------------------------
Number (%) Number (%)
------------------------------------------------------ ----------- ------------- ------------------ ----------
(1) Relevant securities owned
and/or controlled: 1,316,994 0.99% 541,332 0.41%
(2) Cash-settled derivatives:
541,332 0.41% 1,309,835 0.98%
(3) Stock-settled derivatives (including
options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 1,858,326 1.39% 1,851,167 1.39%
(b) Rights to subscribe for new securities (including directors and other executive
options)
Class of relevant security in relation to
which subscription right exists
------------------------------------------------------------------------------ ------- ---------------
Details, including nature of the rights
concerned and relevant percentages:
------------------------------------------------------------------------------ ------- ---------------
3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
(a) Purchases and sales
---------------- ------------------------------ ------------ -------------- ------ -------------- --------------
Class of Purchase/sale Total number Highest price Lowest price
relevant of per unit per unit
security securities paid/received paid/received
---------------- ------------- --------------- ------------ -------------- ------ -------------- --------------
0.1p ordinary Purchase 19,875 9.2395 GBP 9.215 GBP
0.1p ordinary Sale 69,547 9.2450 GBP 9.2214 GBP
----------------------------- ---------------------- -------------- --------------
(b) Cash-settled derivative transactions
---------------- -------------------------------------------- -------------- ------ -------------- --------------
Class of Product Nature of Number of Price per
dealing
relevant description reference unit
security securities
---------------- ------------- --------------- ------------ -------------- ------ -------------- --------------
0.1p ordinary SWAP Decreasing Short 430 9.2400 GBP
----------------------------- ---------------------- -------------- --------------
0.1p ordinary SWAP Decreasing Short 4,572 9.2200 GBP
----------------------------- ---------------------- -------------- --------------
0.1p ordinary SWAP Decreasing Short 12,535 9.2400 GBP
----------------------------- ---------------------- -------------- --------------
0.1p ordinary SWAP Decreasing Short 17,134 9.2364 GBP
----------------------------- ---------------------- -------------- --------------
0.1p ordinary SWAP Decreasing Short 25,005 9.2390 GBP
----------------------------- ---------------------- -------------- --------------
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class Product Writing, Number Exercise Type Expiry Option
of description purchasing, of price date money
relevant selling, securities per unit paid/
security varying etc to which received
option per unit
relates
------------- --------------- ------------ -------------- ------ -------------- --------------
(ii) Exercising
Class of relevant Product description Exercising/ exercised Number of Exercise
against price per
security securities unit
---------------- ------------- --------------- ------------ -------------- --------------
(d) Other dealings (including subscribing for new securities)
Class of Nature of Details Price per
relevant Dealings unit (if
security applicable)
---------------- ------------- --------------- ------------ -------------- --------------
4. OTHER INFORMATION
(a) Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the exempt principal trader making the disclosure
and any party
to the offer or any person acting in concert with a party to the offer:
-------------------------------------------------------------------------------------- -------------- --------------
NONE
----------------------------------------------------------------------------------------------------------------------
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between
the exempt principal trader making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant securities to which
any derivative is referenced:
------------------------------------------------ ------------ -------------- ------ -------------- --------------
NONE
----------------------------------------------------------------------------------------------------------------------
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
------------------------------------------------------
Date of disclosure: 1 Apr 2022
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
---------------------- -------------- --------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
FEOBKDBPCBKKPQK
(END) Dow Jones Newswires
April 01, 2022 05:59 ET (09:59 GMT)
1 Year Clinigen Chart |
1 Month Clinigen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
